Back to HomeBeta

ICD-10 Coding for Empagliflozin(E11.9, I50.23, E11.22)

Complete ICD-10-CM coding and documentation guide for Empagliflozin. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Jardiance

Related ICD-10 Code Ranges

Complete code families applicable to Empagliflozin

E11-E11.9Primary Range

Type 2 Diabetes Mellitus

Empagliflozin is primarily used for managing Type 2 Diabetes Mellitus.

Heart Failure

Empagliflozin is used for heart failure management, particularly HFrEF.

Chronic Kidney Disease

Empagliflozin is used in patients with CKD, especially those with diabetes.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
E11.9Type 2 diabetes mellitus without complicationsUse when managing Type 2 Diabetes Mellitus without specific complications.
  • Diagnosis of Type 2 Diabetes Mellitus
  • HbA1c levels indicating diabetes
I50.23Acute on chronic systolic (congestive) heart failureUse when empagliflozin is prescribed for heart failure with reduced ejection fraction.
  • Ejection fraction ≤40%
  • BNP >100 pg/mL
E11.22Type 2 diabetes mellitus with diabetic chronic kidney diseaseUse when managing Type 2 Diabetes Mellitus with CKD.
  • eGFR <60
  • UACR ≥30 mg/g

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: How is empagliflozin coded in ICD-10?

Essential facts and insights about Empagliflozin

Empagliflozin is coded under Z79.84 for long-term use of oral hypoglycemic drugs, often in conjunction with E11.9 for Type 2 Diabetes Mellitus.

Primary ICD-10-CM Codes for empagliflozin

Type 2 diabetes mellitus without complications
Billable Code

Decision Criteria

clinical Criteria

  • Patient diagnosed with Type 2 Diabetes Mellitus

Applicable To

  • Type 2 diabetes

Excludes

  • Type 1 diabetes (E10.-)

Clinical Validation Requirements

  • Diagnosis of Type 2 Diabetes Mellitus
  • HbA1c levels indicating diabetes

Code-Specific Risks

  • Ensure diabetes type is specified to avoid default coding errors.

Coding Notes

  • Ensure to document the type of diabetes and any associated conditions.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Long term (current) use of oral hypoglycemic drugs

Z79.84
Use with E11.9 when empagliflozin is prescribed.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Type 1 diabetes mellitus without complications

E10.9
Type 1 diabetes is insulin-dependent and typically diagnosed in younger patients.

Acute on chronic diastolic (congestive) heart failure

I50.33
Diastolic heart failure involves preserved ejection fraction.

Chronic kidney disease, unspecified

N18.9
Use N18.9 when CKD is present without diabetes.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Empagliflozin to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code E11.9.

Impact

Clinical: May lead to inappropriate treatment plans., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.

Mitigation Strategy

Always specify Type 2 Diabetes Mellitus when coding., Use E11.9 only when no complications are present.

Impact

Reimbursement: May result in denied claims or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient medication use.

Mitigation Strategy

Always include Z79.84 with E11.9 when empagliflozin is used.

Impact

Failure to code long-term medication use.

Mitigation Strategy

Implement regular audits of medication coding practices.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Empagliflozin, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Empagliflozin

Use these documentation templates to ensure complete and accurate documentation for Empagliflozin. These templates include all required elements for proper coding and billing.

Managing Type 2 Diabetes with CKD

Specialty: Endocrinology

Required Elements

  • Patient's A1C levels
  • eGFR and UACR results
  • Medication adjustments

Example Documentation

Empagliflozin 10mg daily for T2DM with CKD stage 3, A1C 7.1%, eGFR 45.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Continuing Jardiance.
Good Documentation Example
Empagliflozin 10mg daily maintained for T2DM with HbA1c 6.8% and CKD stage 3 (eGFR 45).
Explanation
The good example specifies dosage, condition, and lab results, ensuring comprehensive documentation.

Need help with ICD-10 coding for Empagliflozin? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more